Kem One secures €100M recapitalisation, cutting debt by 80%
What's the deal? Kem OneDealroom has a profile for this one. Try Dealroom →, a French chlorovinyls manufacturer, has struck an agreement in principle with its main financial partners on a €100M recapitalisation that will cut its debt by roughly 80% — a reduction of €720M in net debt.
The deal brings in €30M jointly from Monarch Alternative CapitalDealroom has a profile for this one. Try Dealroom → and AriniDealroom has a profile for this one. Try Dealroom →, €40M in capital from Apollo-managed funds, and a new €30M revolving credit facility. After the restructuring, Kem One's residual debt drops to €154M, with maturity pushed to 2031.
As part of the transaction, Monarch Alternative Capital and Arini become Kem One's reference shareholders, replacing Apollo-managed funds, which has controlled the company since 2022. Arini joins as a minority non-controlling investor. Apollo remains involved through new financing and existing stakes.
Why now? Europe's chlorovinyls industry has been under sustained pressure from high energy costs, weak demand, and what Kem One describes as unfair competition and dumping by non-European producers. Since 2022, the company has invested more than €550M to modernise facilities and improve competitiveness — but that heavy capital expenditure, combined with a tough market, has weighed on its balance sheet.
The restructuring is designed to give Kem One enough liquidity and financial headroom to keep operating while the sector recovers. Interest on the residual debt will be capitalised for the first two years, then payable under a flexible "Pay If You Can" mechanism.
What could go wrong? The deal is still an agreement in principle, not a completed transaction. Market conditions in European chemicals remain difficult, and Kem One's own language — "without underestimating the challenges" — signals continued uncertainty.
Even after the restructuring, €154M in debt remains. If European chlorovinyls markets don't recover or if dumping pressures persist, the company could face renewed financial strain before 2031.
The signal: Kem One's recapitalisation is a case study in how credit-focused and alternative capital players are reshaping ownership of stressed European industrial assets. Monarch Alternative Capital, classified as an investment fund, and Arini are stepping in as reference shareholders of a company still tagged as "early stage" on Dealroom despite operating large-scale chlorochemical facilities — a mismatch that underscores how legacy heavy-industry firms can sit outside typical venture and growth categorisations, making them harder to finance through conventional channels. The deal suggests that as Europe's energy-intensive sectors struggle to reconcile modernisation spending with weak market conditions, distressed-debt specialists will increasingly become the backstop investors of last resort.
Read more: Polymerupdate
